Shu Jin-Hui, Feng Gui-Xue, Li Jin, Li Jia-Xiang, Gan Xian-You, Zhang Bo, Zhou Hong, Liu Yin
Reproductive Medicine Center, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi 530003, China.
Zhonghua Nan Ke Xue. 2013 May;19(5):414-7.
To determine the predictive value of sperm morphology based on the criteria of the 5th edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen (WHO5) on the outcomes and neonatal status following IVF-ET.
According to the strict criteria of WHO5, we obtained semen samples from 789 subjects and allocated them to a normal group (morphologically normal sperm > or = 4%, 754 cycles) and a teratozoospermia group (morphologically normal sperm < 4%, 35 cycles). We made comparisons between the two groups in the rates of normal fertilization, cleavage, quality embryo, implantation, clinical pregnancy and miscarriage as well as the status of the neonates.
No significant differences were observed in the couples' age, mean number of oocytes, and mean stature and body mass index of the women between the two groups (P > 0.05). The teratozoospermia group showed slightly lower rates of fertilization, cleavage, quality embryo, embryo cryopreservation, implantation and pregnancy, but a higher rate of miscarriage than the normal group (P > 0.05). Apart from 141 on-going pregnancies (140 in the normal and 1 in the teratozoospermia group), 228 healthy infants were born following 789 transfer cycles, 213 (141 singletons and 36 twins) in the former and 15 (9 singletons and 3 twins) in the latter group. Congenital defects were found in none of the neonates, and there were no significant differences in the gestation period, premature birth rate and low body weight between the two groups (P > 0.05).
Sperm morphology according to the criteria of WHO5 has but a limited value in predicting the outcomes and neonatal status following IVF-ET.
根据世界卫生组织《人类精液检查与处理实验室手册》第5版(WHO5)标准,确定精子形态对体外受精-胚胎移植(IVF-ET)结局及新生儿状况的预测价值。
按照WHO5的严格标准,我们收集了789名受试者的精液样本,并将其分为正常组(形态正常精子≥4%,754个周期)和畸形精子症组(形态正常精子<4%,35个周期)。我们比较了两组在正常受精率、卵裂率、优质胚胎率、着床率、临床妊娠率和流产率以及新生儿状况方面的差异。
两组在夫妇年龄、平均卵母细胞数以及女性的平均身高和体重指数方面均未观察到显著差异(P>0.05)。畸形精子症组的受精率、卵裂率、优质胚胎率、胚胎冷冻保存率、着床率和妊娠率略低于正常组,但流产率高于正常组(P>0.05)。除141例正在妊娠外(正常组140例,畸形精子症组1例),789个移植周期后共出生228名健康婴儿,正常组213名(141名单胎和36对双胞胎),畸形精子症组15名(9名单胎和3对双胞胎)。所有新生儿均未发现先天性缺陷,两组在妊娠期、早产率和低体重方面也无显著差异(P>0.05)。
根据WHO5标准的精子形态在预测IVF-ET结局及新生儿状况方面价值有限。